Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Novo Nordisk A/S banner

Novo Nordisk A/S
XMUN:NOV

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
XMUN:NOV
Watchlist
Price: 35.175 EUR 0.09% Market Closed
Market Cap: €119.1B
Write Note Create Alert Ask AI

Bankruptcy Probability

Novo Nordisk A/S's probability of bankruptcy is 1%, making a collapse highly unlikely. The solvency score is 68/100 — a warning sign of potential financial weakness.

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Very Low
Probability of Bankruptcy

Financial Position

Cash & Short-Term Investments
+
3Y
+24%
5Y
+65%
10Y
+196%
Long-Term Investments
+
3Y
+58%
5Y
+27%
10Y
+20%
Debt
+
3Y
+527%
5Y
+877%
10Y
+29 899%

Solvency Ratios

Solvency Ratios Comparison
Novo Nordisk A/S Competitors

Country Company Market Cap D/E D/A Interest
Coverage 		Altman
Z-Score 		Quick
Ratio 		Current
Ratio 		Cash
Ratio
DK
Novo Nordisk A/S
CSE:NOVO B
1.2T DKK
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1.2T USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
358.6B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
237.6B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
171.1B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DE
Bayer AG
XETRA:BAYN
43.2B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
635.3B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
OTC:RHHBF
392.7B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
243.3B CHF
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
198.9B GBP
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CA
Nuvo Pharmaceuticals Inc
TSX:MRV
270.3B CAD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Continue NOV Research

Summary
NOV intrinsic value, competitors valuation, and company profile.
DCF Valuation
NOV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NOV stock valuation using valuation multiples.
Wall St Estimates
NOV price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NOV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Novo Nordisk A/S listings:
NYSE • USD
NVO
 OTC • USD
NONOF
 F • EUR
NOVA
 CSE • DKK
NOVO B
 XETRA • EUR
NOV
 F • EUR
NOV
 XMUN • EUR
NOVA
 SWB • EUR
NOV
 SWB • EUR
NOVA
 DUS • EUR
NOV
 DUS • EUR
NOVA
 XHAM • EUR
NOV
 BMV • MXN
NVON
 LSE • USD
0TDD
Discover More
Is Novo Nordisk A/S at risk of bankruptcy?

Novo Nordisk A/S's probability of bankruptcy is 1%, making a collapse highly unlikely.

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Novo Nordisk A/S have?

As of the latest report, Novo Nordisk A/S has total debt of 121.8B DKK. This includes both short-term (0 DKK) and long-term (121.8B DKK) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
ALPHA SPREAD
Follow us
Join 362,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.